Received Aug 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 1 | — | — |
Caller did not report any side effects; Caller called to report that they received a pediatric dose of RECOMBIVAX on 7/13 and they are 20 years old. Caller stated that for them to go to store to get an adult dose on 8/15. Caller did not report any side effects. Permission to contact HCP was; This spontaneous report was received from a 20-year-old consumer referring to themself. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 13-Jul-2025, the patient was vaccinated with a pediatric dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), dose number 1, (lot # and expiration date were not reported) for prophylaxis (underdose). No adverse event was reported.